ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
(MM)

(MM) (QCOR)

93.60
0.00
(0.00%)
Closed September 18 4:00PM
93.60
0.00
( 0.00% )
Pre Market: 8:00PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
93.60
Bid
0.00
Ask
0.00
Volume
0.00
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
93.60
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

QCOR Latest News

Mallinckrodt Set to Join the S&P 500; Rowan to Join S&P MidCap 400; GulfMark Offshore to Join S&P SmallCap 600

Mallinckrodt Set to Join the S&P 500; Rowan to Join S&P MidCap 400; GulfMark Offshore to Join S&P SmallCap 600 PR Newswire NEW YORK, Aug. 14, 2014 NEW YORK, Aug. 14, 2014 /PRNewswire/...

Mallinckrodt Completes Acquisition Of Questcor Pharmaceuticals

Mallinckrodt Completes Acquisition Of Questcor Pharmaceuticals - Creates a diversified, high-growth therapeutic portfolio, capable of delivering substantial, sustainable value for shareholders...

Mallinckrodt And Questcor Shareholders Approve Mallinckrodt's Acquisition Of Questcor

Mallinckrodt And Questcor Shareholders Approve Mallinckrodt's Acquisition Of Questcor PR Newswire DUBLIN and ANAHEIM, Calif., Aug. 14, 2014 DUBLIN and ANAHEIM, Calif., Aug. 14, 2014 /PRNewswire/...

Institutional Shareholder Services Inc. And Glass Lewis Recommend That Shareholders Of Mallinckrodt And Questcor Vote FOR Mal...

Institutional Shareholder Services Inc. And Glass Lewis Recommend That Shareholders Of Mallinckrodt And Questcor Vote FOR Mallinckrodt's Acquisition Of Questcor PR Newswire DUBLIN and ANAHEIM...

Greenlight Notes Short Positions in Safeway, Lorillard -Reuters

Greenlight Capital Inc.'s David Einhorn on Friday disclosed the hedge fund has taken short positions in Safeway Inc. (SWY), Lorillard Inc. (LO), Martin Marietta Materials Inc. (MLM) and Questcor...

Questcor Reports Record Second Quarter Financial Results

Questcor Reports Record Second Quarter Financial Results Net Sales $279 Million; Increase of 42% over Prior Year Non-GAAP Results GAAP EPS of $1.54, Non-GAAP EPS of $1.85 up 37...

Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction

Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction --Registration Statement on Form S-4 Declared Effective by SEC-- --Record Dates for Mallinckrodt and...

Questcor Pharmaceuticals Closes Transaction to Acquire International Rights to Synacthen® and Synacthen® Depot

Questcor Pharmaceuticals Closes Transaction to Acquire International Rights to Synacthen® and Synacthen® Depot - Initiates Global Footprint, Diversifies Business, Enhances Long-term Growth...

Questcor Provides Support to Lupus Foundation of America Awareness, Education and Advocacy Efforts

Questcor Provides Support to Lupus Foundation of America Awareness, Education and Advocacy Efforts Company sponsors Walk to End Lupus Now™ events and employees show support for people with the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TBIOTelesis Bio Inc
$ 3.56
(161.76%)
15.67M
XCURExicure Inc
$ 5.80
(153.28%)
5.09M
ZEOZeo Energy Corporation
$ 2.79
(144.74%)
6.79M
RZLVRezolve AI Ltd
$ 9.64
(102.95%)
1.29M
VEROVenus Concept Inc
$ 0.8301
(65.19%)
6.74M
HAOHaoxi Health Technology Ltd
$ 2.13
(-29.00%)
138.72k
PGNYProgyny Inc
$ 18.35
(-24.92%)
212.89k
SBCSBC Medical Group Holdings Incorporated
$ 5.95
(-22.32%)
33.07k
VVOSVivos Therapeutics Inc
$ 3.25
(-21.31%)
818.67k
WBUYWeBuy Global Ltd
$ 0.1468
(-20.35%)
2.59M
FRGTFreight Technologies Inc
$ 0.167
(34.79%)
44.58M
MAXNMaxeon Solar Technologies Ltd
$ 0.0979
(7.70%)
22.09M
TBIOTelesis Bio Inc
$ 3.56
(161.76%)
15.67M
SQQQProShares UltraPro Short QQQ
$ 7.875
(-6.25%)
13.09M
ACHLAchilles Therapeutics PLC
$ 1.02
(43.66%)
12.72M

QCOR Discussion

View Posts
protagonist12 protagonist12 10 years ago
Selloff down to the teens due to Achtar dropped coverage fiasco 2 years ago, and nice climb back up to 90s thanks to Andrew Left and Citron Research. He'll have a tough time thrashing Achtar now that its owned by Mallinckrodt behemoth. But the short squeeze on this stock with over 100% institutional ownership was sorta weird.
👍️0
elbiatcho1 elbiatcho1 10 years ago
Mallinckrodt Completes Acquisition Of Questcor Pharmaceuticals

- Creates a diversified, high-growth therapeutic portfolio, capable of delivering substantial, sustainable value for shareholders- Significantly increases Mallinckrodt's scale, revenues, profitability and cash flow- Expected to be immediately accretive to Mallinckrodt's fiscal 2014 adjusted diluted earnings per share; significantly accretive to adjusted diluted earnings per share in fiscal 2015

DUBLIN, Aug. 14, 2014 /PRNewswire/ -- Mallinckrodt plc MNK +1.82% , a leading global specialty pharmaceutical company, today announced that it has completed its acquisition of Questcor Pharmaceuticals, Inc. QCOR +1.65% in a cash and stock transaction valued at approximately $5.8 billion. The acquisition is expected to be immediately accretive to Mallinckrodt's fiscal 2014 adjusted diluted earnings per share and significantly accretive to its adjusted diluted earnings per share in fiscal 2015.

The merger follows strong approval by both Mallinckrodt and Questcor shareholders at separate special meetings held today. Under the terms of the merger agreement, Questcor shareholders will receive $30.00 in cash and 0.897 of a Mallinckrodt ordinary share for each Questcor share.

"We are pleased to complete this transformative transaction and believe it will provide a strong, durable, well-diversified and sustainable platform, capable of generating significant future revenue and earnings growth for Mallinckrodt shareholders," said Mark Trudeau, President and Chief Executive Officer of Mallinckrodt. "HP Acthar® Gel has demonstrated success in treating patients suffering from a variety of devastating and difficult-to-treat autoimmune and inflammatory illnesses. We are confident that Acthar will be a strong complement to Mallinckrodt's broadening portfolio of leading specialty pharmaceutical brands, and we look forward to leveraging our extensive manufacturing and scientific expertise, as well as our experience with advocacy and payer communities, to capitalize on the many opportunities it presents."

Mr. Trudeau added, "We are very pleased to welcome the Questcor team to Mallinckrodt. We are excited about our future prospects and the benefits that our collective efforts will have for patients, our investors and the communities that we serve."

As previously disclosed, commercial operations supporting HP Acthar Gel will function as a separate business within Mallinckrodt's Specialty Pharmaceuticals segment reporting to Mr. Trudeau. It will be known as the Autoimmune and Rare Diseases business within Mallinckrodt.
...
http://www.marketwatch.com/story/mallinckrodt-completes-acquisition-of-questcor-pharmaceuticals-2014-08-14

Its done. Maybe see ya on the other side.
👍️0
stocktrademan stocktrademan 10 years ago
Questcor Pharmaceuticals, Inc. [$QCOR] due diligence

bullish short squeeze

$QCOR

DD Notes ~ http://www.ddnotesmaker.com/QCOR

##### recent news/filings ~ source: finance.yahoo.com

Mon, 30 Jun 2014 22:07:14 GMT ~ Questcor And Mallinckrodt: The Good, The Bad, And The Ugly
read full: http://seekingalpha.com/article/2293805-questcor-and-mallinckrodt-the-good-the-bad-and-the-ugly?source=yahoo
*********************************************************

Mon, 30 Jun 2014 15:53:00 GMT ~ Hey Mallinckrodt, Pay Close Attention - UnitedHealth Just Slammed Questcor's Acthar
read full: http://seekingalpha.com/article/2292885-hey-mallinckrodt-pay-close-attention-unitedhealth-just-slammed-questcors-acthar?source=yahoo
*********************************************************

Thu, 26 Jun 2014 21:47:01 GMT ~ Why Small-Cap Stocks ARRIS and Questcor Have Huge Growth Potential
read full: http://www.fool.com/investing/general/2014/06/26/why-small-cap-stocks-arris-and-questcor-have-huge.aspx?source=eogyholnk0000001
*********************************************************

Wed, 25 Jun 2014 17:49:25 GMT ~ The FDA Owes Us An Answer On Questcor's Acthar
read full: http://seekingalpha.com/article/2286053-the-fda-owes-us-an-answer-on-questcors-acthar?source=yahoo
*********************************************************

Mon, 23 Jun 2014 13:00:00 GMT ~ Questcor Pharmaceuticals Closes Transaction to Acquire International Rights to Synacthen® and Synacthen® Depot
[PR Newswire] - ANAHEIM, Calif., June 23, 2014 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (QCOR) today announced that the transaction acquiring rights to Synacthen® and Synacthen® Depot from Novartis Pharma AG and Novartis AG in certain countries outside the U.S. has now closed. Available in more than forty countries for multiple indications, Synacthen (tetracosactide) is a synthetic 24 amino acid melanocortin peptide. Synacthen Depot is a depot formulation of Synacthen. The products are approved outside the U.S. for multiple indications, including certain autoimmune and inflammatory conditions as well as for diagnostic use, but have never been developed or approved for patients in the U.S. Questcor is presently engaged in pre-clinical development for Synacthen in the U.S. "As a leader in melanocortin peptide therapeutics, we now have the opportunity with Synacthen to expand our commercial presence to more than forty international markets, and develop a new potential platform for international growth in this important emerging field of medicine," said Steve Cartt, Chief Operating Officer of Questcor.
read full: http://finance.yahoo.com/news/questcor-pharmaceuticals-closes-transaction-acquire-130000695.html
*********************************************************

##### chart ~ source: stockcharts.com



##### chart ~ source: eoddata.com



##### company info ~ source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/QCOR/company-info
Ticker: $QCOR
OTC Market Place: Not Available
CIK code: 0000891288
Company name: Questcor Pharmaceuticals, Inc.
Company website: http://www.questcor.com
Incorporated In: CA, USA

##### extra dd links

Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000891288&owner=exclude&count=40
Latest filings: http://www.otcmarkets.com/stock/QCOR/filings
Latest financials: http://www.otcmarkets.com/stock/QCOR/financials
Latest news: http://www.otcmarkets.com/stock/QCOR/news - http://finance.yahoo.com/q/h?s=QCOR+Headlines

Major holdings: http://data.cnbc.com/quotes/QCOR/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=QCOR+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/QCOR.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=QCOR

RegSho: http://www.regsho.com/tools/symbol_stats.php?sym=QCOR&search=search

DTCC: http://search2.dtcc.com/?q=Questcor+Pharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&q=Questcor+Pharmaceuticals%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results?term=Questcor+Pharmaceuticals%2C+Inc.&x=0&y=0
WHOIS: http://whois.domaintools.com/http://www.questcor.com
Alexa: http://www.alexa.com/siteinfo/http://www.questcor.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.questcor.com

Short Sales: http://www.otcmarkets.com/stock/QCOR/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/QCOR/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/QCOR/research
Historical Prices: http://finance.yahoo.com/q/hp?s=QCOR+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=QCOR+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=QCOR+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=QCOR+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=QCOR+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=QCOR+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=QCOR
Balance Sheet: http://finance.yahoo.com/q/bs?s=QCOR
Cash Flow: http://finance.yahoo.com/q/cf?s=QCOR+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/QCOR
Bloomberg: http://www.bloomberg.com/quote/QCOR:US
Morningstar: http://quotes.morningstar.com/stock/s?t=QCOR
Bussinessweek: http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=QCOR
Barchart: http://www.barchart.com/quotes/stocks/QCOR
OTC Short Report: http://otcshortreport.com/index.php?index=QCOR
Investopedia: http://www.investopedia.com/markets/stocks/QCOR/?wa=0

http://www.pennystocktweets.com/stocks/profile/QCOR

##### last known share structure ~ source: otcmarkets.com

Market Value: $5,639,764,117 a/o
Shares Outstanding: 60,977,015 a/o Mar 31, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value

##### business description ~ source: otcmarkets.com



DD Notes ~ http://www.ddnotesmaker.com/QCOR

👍️0
elbiatcho1 elbiatcho1 10 years ago
That's a nice bonus, sheesh.

ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.

On May 13, 2014, Questcor Pharmaceuticals, Inc. (the “Company”) entered into an amendment (the “Asarpota Amendment”) to the severance agreement with Rajesh Asarpota, the Company’s Senior Vice President, Chief Financial Officer. Under the Asarpota Amendment, if the proposed merger with Mallinckrodt plc and Quincy Merger Sub, Inc. is consummated and an excise tax is imposed on Mr. Asarpota as a result of any compensation or benefits provided to Mr. Asarpota in connection with the consummation of the proposed merger, the Company will pay or reimburse Mr. Asarpota an amount equal to such excise tax plus any taxes resulting from such payment or reimbursement.
👍️0
elbiatcho1 elbiatcho1 10 years ago
Old news from February.

Citron has been attacking QCOR for a long time and is probably involved in the major shorting activity that has hit the stock repeatedly.

That new article from the "analyst firm" is simply a lawyer shopping for invidivuals who feel they've been deceived.
👍️0
investorguy84 investorguy84 10 years ago
Looks like an analyst firm issued a couple of reports on the company's acthar drug. A law firm wrote a blog article that looks like they picked up on this analyst report.

insert-text-here

insert-text-here

insert-text-here


I'm not sure what to think about this. Any thoughts? This seems like a pretty damaging report.

👍️0
stockmavin stockmavin 10 years ago
You are right. They all seem to be jumping onto the bandwagon now.
👍️0
Topgun21 Topgun21 10 years ago
Congrats QCOR on your Buyout! Nicely Done!!


Regards,
Tim
👍️0
elbiatcho1 elbiatcho1 10 years ago
There is almost always an investigation whenever any company sells out/merges.

I don't think this has anything to do with shorts.

Just typical lawyers looking for some income using the usual lingo:
The investigation focuses on whether Questcor's Board of Directors breached their fiduciary duties to the Company's stockholders by failing to conduct a fair sales process and whether and by how much this proposed transaction undervalues the Company to the detriment of Questcor's shareholders.
👍️0
stockmavin stockmavin 10 years ago
"Faruqi & Faruqi, LLP Announces the Investigation of Questcor Pharmaceuticals Inc. (QCOR) Over the Proposed Sale of the Company to Mallinckrodt plc"

Sounds like the shorts are upset on their big losses. imo
👍️0
stockmavin stockmavin 10 years ago
So glad they get what they deserve!
👍️0
elbiatcho1 elbiatcho1 10 years ago
80-100? Lmao.
Rather amazing when poster was spot on?... although it took a couple more years.
👍️0
Joe89 Joe89 10 years ago
Congrats on the buyout QCOR shareholders!
👍️0
elbiatcho1 elbiatcho1 10 years ago
Twas a nice run everyone.
Congrats to the longs, been in it since 1.25.
👍️0
FairviewInvestor FairviewInvestor 10 years ago
and the shorts get crushed...
👍️0
StickyStock StickyStock 11 years ago
Nice Roth pick here
👍️0
Wallstreetcounter Wallstreetcounter 11 years ago
New report out Wallstreetcounterpoint.com on QCOR
👍️0
stockmavin stockmavin 11 years ago
smh...Universal Commodity Corporation
👍️0
Rawnoc Rawnoc 11 years ago
QCOR -- just shorted at $57.335 average based on this report and tons before it:

http://www.citronresearch.com/wp-content/uploads/2013/12/QCOR1203-update-final.pdf
👍️0
ECole ECole 11 years ago
Interesting presentation at Credit-Suisse-Healthcare-Conference


http://www.earningsimpact.com/Transcript/84507/QCOR/2013-Credit-Suisse-Healthcare-Conference
👍️0
ECole ECole 11 years ago
Q2 2013, 177 million of Acthar sales, up 57% from the prior period.

Call transcript
http://www.earningsimpact.com/Transcript/82494/QCOR/Q2-2013-Earnings-Call
👍️0
elbiatcho1 elbiatcho1 11 years ago
Seems like a huge jump in sales.
Net sales for the second quarter ended June 30, 2013 were $184.6 million, up 64% from $112.5 million in the second quarter of 2012.
http://ih.advfn.com/p.php?pid=nmona&article=58610511&symbol=QCOR

No wonder big a/h spike.
👍️0
mkinhaw mkinhaw 11 years ago
New all time hi 59.00 a/h s

wow

MK
👍️0
SilverSurfer SilverSurfer 11 years ago
bullish consolidation after breakout

👍️0
TheFinalCD TheFinalCD 11 years ago
wow nice sell right at the T.O.P
👍️0
deadboy deadboy 11 years ago
Got in today, hope the party isn't over
👍️0
MARINO MARINO 11 years ago
DBEN out at $46.45
👍️0
The Night Stalker The Night Stalker 11 years ago
was in this at 1.50 in 2007,, sold for 2.50 and now it creeps up big many years late.
👍️0
MARINO MARINO 11 years ago
And we are UP !
👍️0
TheFinalCD TheFinalCD 11 years ago
Big NEWS,
👍️0
MARINO MARINO 11 years ago
Yep and with excellent news
👍️0
TheFinalCD TheFinalCD 11 years ago
wow opened HOD $50 and closed LOD
👍️0
MARINO MARINO 11 years ago
DBEN in at $42
👍️0
protagonist12 protagonist12 11 years ago
Yeah strange AH dip on blowout earnings. A similar thing happened after 2012 Q4 earnings report. QCOR blew away analysts EPS forcasts by .30 a share and yet the thing traded sideways for months.

You have to wonder why this stock has been in a holding pattern for 6 over months, but I guess there are still questions as to whether or not Achtar will be covered by major policies such as Aetna. Gee I wonder if Andrew Left and Citron Research is still shorting this.
👍️0
investingdog investingdog 11 years ago
Unusual AH trading after the earnings. Record April sales lifted the stock after the initial drop. It will be interesting tomorrow.
👍️0
stockmavin stockmavin 12 years ago
Nice results. Beat the street estimate and increased divi.

👍️0
Its A Whiz Its A Whiz 12 years ago
Go QCOR LONG!!! big epic spike going to happen if this goes over $32, valuation $90, earnings 26th no replay of last time going to happen, shorts will be exiting the building enmass soon, Funds are buying in big. Technicals have changed to positive. Short term $45 long term $100 plus. New VP is a buyout negotiator, $$$$
👍️0
Nebuchadnezzar Nebuchadnezzar 12 years ago
and $26 appears to be a crucial level

hard to see just how much accumulation is taking place, but keep an eye on $25-$26 price level in which we are currently in
👍️0
Sry8 Sry8 12 years ago
Very quite in here. After days doing DD, I'm all in. Picked up @ $26.83. No debt and increasing revenue this stock has potential. Glta!
👍️0
StockConsultant_com StockConsultant_com 12 years ago
QCOR continuation breakout watch above 28.6

looks like another run but could use more volume

BREAKOUT WATCH for possible breakout above 28.6, no resistance in area just above.
Type: Continuation breakout from single resistance.
Target: 32.21, 13.2% Stop: 27.33, Loss: 4%, Profit/Loss ratio: 3.3 : 1 - Excellent

CURRENT PRICE 28.46, at resistance, 27.79 ± 0.81, type single, strength 1

RESISTANCE ABOVE +23.9% at 35.27 ± 1.02, type single, strength 3
+36.2% at 38.75 ± 1.12, type double, strength 7
+42.1% at 40.44 ± 1.17, type triple, strength 5

source: http://www.stockconsultant.com/consultnow/basicplus.cgi?symbol=QCOR
👍️0
stockmavin stockmavin 12 years ago
After all of these baseless class actions fail, I would love to see the company go after not only those Law firms for defamation, but also that shorter blog or website that I believe had some large monetary motive in contacting the firms.
👍️0
jas1n jas1n 12 years ago
big move today and I dont see any news that would have made it go up like it did
👍️0
frosr6 frosr6 12 years ago
HUGE INSIDER BUYING

Ready for a run up!!!

PURCHASED
11/5/2012 55,000 shares@ 23.92 for a total of $1,315,400!!
11/2/2012 10,000 shares@ 24.17 for a total of $241,696


http://www.secform4.com/insider-trading/891288.htm
👍️0
Nebuchadnezzar Nebuchadnezzar 12 years ago
earnings did not disappoint but how about that nice call on market selling off, it's not done yet, but QCOR may still go up with positive earnings, but there are investigations/lawsuits so I honestly would be a little hesitant to continue playing with fire, that's all

there is only one stock i want to see tank and that is KCG and maybe GS

good luck to all here, hopefully nothing to serious with whatever is going on behind the scenes and may $30+ return
👍️0
fafssaf fafssaf 12 years ago
QCOR beats estimates! EPS of 0.91 from an estimate of 0.75. Tomorrow should be interesting.
👍️0
zephyroo zephyroo 12 years ago
been a helluva ride past couple days.
👍️0
armchairboogie armchairboogie 12 years ago
Looks as if today's bear raid failed hard and fast.
👍️0
shankapotamus shankapotamus 12 years ago
Look out belowwww
👍️0
gixxer11 gixxer11 12 years ago
Rut ro
👍️0
philca philca 12 years ago
Good start for today...
👍️0

Your Recent History

Delayed Upgrade Clock